Showing results (1-10 of 1,062) with videos related to
Sort By:
Pageof 107
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
The biosimilar road in inflammatory bowel disease: the right way?Gionata Fiorino, Silvio DaneseCurrent Medicinal Chemistry|May 15, 2018
Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's ProfileSilvio Danese, Gionata FiorinoDigestive Diseases (Basel, Switzerland)|September 14, 2013
Cross-sectional imaging modalities in Crohn's diseaseMariangela Allocca, Gionata Fiorino, Silvio DaneseJournal of Crohn'S & Colitis|April 27, 2016
Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated SurveySilvio Danese, Gionata Fiorino, Pierre MichettiCurrent Drug Targets|September 13, 2014
Iron deficiency: the hidden miscreant in inflammatory bowel diseaseMariangela Allocca, Gionata Fiorino, Silvio DaneseJournal of Crohn'S & Colitis|July 11, 2014
Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis OrganizationSilvio Danese, Gionata Fiorino, Pierre MichettiExpert Review of Clinical Immunology|July 28, 2015
Adalimumab for the treatment of pediatric Crohn's diseaseFederica Nuti, Gionata Fiorino, Silvio DaneseCurrent Drug Targets|April 7, 2011
Biological therapy for ulcerative colitis: what is after anti-TNFGionata Fiorino, Monica Cesarini, Silvio DaneseCurrent Drug Targets|June 11, 2013
Anti-IL-13 in inflammatory bowel disease: from the bench to the bedsideManol Jovani, Gionata Fiorino, Silvio DaneseTherapeutic Advances in Gastroenterology|July 2, 2016
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopesGionata Fiorino, Daniela Gilardi, Silvio DanesePageof 107